|
1
|
Bergström A, Pisani P, Tenet V, Wolk A and
Adami HO: Overweight as an avoidable cause of cancer in Europe. Int
J Cancer. 91:421–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hsing AW, Chua S Jr, Gao YT, Gentzschein
E, Chang L, Deng J and Stanczyk FZ: Prostate cancer risk and serum
levels of insulin and leptin: A population-based study. J Natl
Cancer Inst. 93:783–789. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray GA: The underlying basis for obesity:
Relationship to cancer. J Nutr. 132 Suppl:S3451–S3455. 2002.
|
|
4
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allott EH, Masko EM and Freedland SJ:
Obesity and prostate cancer: Weighing the evidence. Eur Urol.
63:800–809. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hoda MR, Mohammed N, Theil G, Fischer K
and Fornara P: Obesity and prostate cancer. Role of adipocytokines
and clinical implications. Urologe A. 51:1253–1260. 2012.(In
German).
|
|
7
|
Hoda MR, Theil G, Mohammed N, Fischer K
and Fornara P: The adipocyte-derived hormone leptin has
proliferative actions on androgen-resistant prostate cancer cells
linking obesity to advanced stages of prostate cancer. J Oncol.
2012:2803862012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao Y and Giovannucci E: Obesity and
prostate cancer. Recent Results Cancer Res. 208:137–153. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patel SB, Reams GP, Spear RM, Freeman RH
and Villarreal D: Leptin: Linking obesity, the metabolic syndrome,
and cardiovascular disease. Curr Hypertens Rep. 10:131–137. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaur J: A comprehensive review on
metabolic syndrome. Cardiol Res Pract. 2014:9431622014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mantzoros CS: The role of leptin in human
obesity and disease: A review of current evidence. Ann Intern Med.
130:671–680. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Klok MD, Jakobsdottir S and Drent ML: The
role of leptin and ghrelin in the regulation of food intake and
body weight in humans: A review. Obes Rev. 8:21–34. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Halaas JL, Gajiwala KS, Maffei M, Cohen
SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM:
Weight-reducing effects of the plasma protein encoded by the obese
gene. Science. 269:543–546. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cummings DE and Foster KE: Ghrelin-leptin
tango in body-weight regulation. Gastroenterology. 124:1532–1535.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Konturek PC, Konturek JW,
Cześnikiewicz-Guzik M, Brzozowski T, Sito E and Konturek SJ:
Neuro-hormonal control of foodintake: Basic mechanisms and clinical
implications. J Physiol Pharmacol. 56 Suppl 6:5–25. 2005.
|
|
16
|
Perry B and Wang Y: Appetite regulation
and weight control: The role of gut hormones. Nutr Diabetes.
2:e262012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maffei M, Halaas J, Ravussin E, Pratley
RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al:
Leptin levels in human and rodent: Measurement of plasma leptin and
ob RNA in obese and weight-reduced subjects. Nat Med. 1:1155–1161.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Friedman JM and Halaas JL: Leptin and the
regulation of body weight in mammals. Nature. 395:763–770. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tartaglia LA, Dembski M, Weng X, Deng N,
Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J,
et al: Identification and expression cloning of a leptin receptor,
OB-R. Cell. 83:1263–1271. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cioffi JA, Shafer AW, Zupancic TJ,
Smith-Gbur J, Mikhail A, Platika D and Snodgrass HR: Novel B219/OB
receptor isoforms: Possible role of leptin in hematopoiesis and
reproduction. Nat Med. 2:585–589. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ahima RS and Flier JS: Leptin. Annu Rev
Physiol. 62:413–437. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Malendowicz W, Rucinski M, Macchi C,
Spinazzi R, Ziolkowska A, Nussdorfer GG and Kwias Z: Leptin and
leptin receptors in the prostate and seminal vesicles of the adult
rat. Int J Mol Med. 18:615–618. 2006.PubMed/NCBI
|
|
24
|
Maamra M, Bidlingmaier M, Postel-Vinay MC,
Wu Z, Strasburger CJ and Ross RJ: Generation of human soluble
leptin receptor by proteolytic cleavage of membrane-anchored
receptors. Endocrinology. 142:4389–4393. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ge H, Huang L, Pourbahrami T and Li C:
Generation of soluble leptin receptor by ectodomain shedding of
membrane-spanning receptors in vitro and in vivo. J Biol Chem.
277:45898–45903. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schultz SC and Widmaier EP: Leptin
receptorsLeptin. Castracane VD and Henson MC: 25. Springer;
Endocrine Updates, Heidelberg: pp. 11–31. 2007, View Article : Google Scholar
|
|
27
|
Wada N, Hirako S, Takenoya F, Kageyama H,
Okabe M and Shioda S: Leptin and its receptors. J Chem Neuroanat
61–62. 191–199. 2014. View Article : Google Scholar
|
|
28
|
Stattin P, Söderberg S, Hallmans G, Bylund
A, Kaaks R, Stenman UH, Bergh A and Olsson T: Leptin is associated
with increased prostate cancer risk: A nested case-referent study.
J Clin Endocrinol Metab. 86:1341–1345. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Malendowicz W and Kwias Z: Leptin receptor
isoforms in benign prostatic hyperplasia (BPH). BPH and prostate
cancer - no association between plasma concentrations of leptin and
prostate specific antigen (PSA). Cent European J Urol. 62:96–100.
2009. View Article : Google Scholar
|
|
30
|
Onuma M, Bub JD, Rummel TL and Iwamoto Y:
Prostate cancer cell-adipocyte interaction: Leptin mediates
androgen-independent prostate cancer cell proliferation through
c-Jun NH2-terminal kinase. J Biol Chem. 278:42660–42667. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Somasundar P, Frankenberry KA, Skinner H,
Vedula G, McFadden DW, Riggs D, Jackson B, Vangilder R, Hileman SM
and Vona-Davis LC: Prostate cancer cell proliferation is influenced
by leptin. J Surg Res. 118:71–82. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Paschke L, Rucinski M, Ziolkowska A,
Zemleduch T, Malendowicz W, Kwias Z and Malendowicz LK: ZFP91 - a
newly described gene potentially involved in prostate pathology.
Pathol Oncol Res. 20:453–459. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Szyszka M, Paschke L, Tyczewska M,
Rucinski M, Grabowska P and Malendowicz LK: Lack of expression of
preproorexin and orexin receptors genes in human normal and
prostate cancer cell lines. Folia Histochem Cytobiol. 53:333–341.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rucinski M, Albertin G, Spinazzi R,
Ziolkowska A, Nussdorfer GG and Malendowicz LK: Cerebellin in the
rat adrenal gland: Gene expression and effects of CER and
(des-Ser1)CER on the secretion and growth of cultured
adrenocortical cells. Int J Mol Med. 15:411–415. 2005.PubMed/NCBI
|
|
35
|
Rucinski M, Ziolkowska A, Tyczewska M and
Malendowicz LK: Expression of prepro-ghrelin and related receptor
genes in the rat adrenal gland and evidences that ghrelin exerts a
potent stimulating effect on corticosterone secretion by cultured
rat adrenocortical cells. Peptides. 30:1448–1455. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tyczewska M, Rucinski M, Ziolkowska A,
Szyszka M, Trejter M, Hochol-Molenda A, Nowak KW and Malendowicz
LK: Enucleation-induced rat adrenal gland regeneration: Expression
profile of selected genes involved in control of adrenocortical
cell proliferation. Int J Endocrinol. 2014:1303592014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Markowska A, Belloni AS, Rucinski M,
Parenti AR, Nardelli GB, Drews K, Nussdorfer GG and Malendowicz LK:
Leptin and leptin receptor expression in the myometrium and uterine
myomas: Is leptin involved in tumor development? Int J Oncol.
27:1505–1509. 2005.PubMed/NCBI
|
|
38
|
Noda T, Kikugawa T, Tanji N, Miura N, Asai
S, Higashiyama S and Yokoyama M: Long-term exposure to leptin
enhances the growth of prostate cancer cells. Int J Oncol.
46:1535–1542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Somasundar P, Yu AK, Vona-Davis L and
McFadden DW: Differential effects of leptin on cancer in vitro. J
Surg Res. 113:50–55. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bub JD, Miyazaki T and Iwamoto Y:
Adiponectin as a growth inhibitor in prostate cancer cells. Biochem
Biophys Res Commun. 340:1158–1166. 2006. View Article : Google Scholar : PubMed/NCBI
|
